Anticoagulation Use and Endovascular Thrombectomy in Patients with Large Core Stroke: A Secondary Analysis of the SELECT2 Trial.
Journal
Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449
Informations de publication
Date de publication:
22 Jul 2024
22 Jul 2024
Historique:
revised:
30
05
2024
received:
03
11
2023
accepted:
16
06
2024
medline:
23
7
2024
pubmed:
23
7
2024
entrez:
23
7
2024
Statut:
aheadofprint
Résumé
Endovascular thrombectomy (EVT) safety and efficacy in patients with large core infarcts receiving oral anticoagulants (OAC) are unknown. In the SELECT2 trial (NCT03876457), 29 of 180 (16%; vitamin K antagonists 15, direct OACs 14) EVT, and 18 of 172 (10%; vitamin K antagonists 3, direct OACs 15) medical management (MM) patients reported OAC use at baseline. EVT was not associated with better clinical outcomes in the OAC group (EVT 6 [4-6] vs MM 5 [4-6], adjusted generalized odds ratio 0.89 [0.53-1.50]), but demonstrated significantly better outcomes in patients without OAC (EVT 4 [3-6] vs MM 5 [4-6], adjusted generalized odds ratio 1.87 [1.45-2.40], p = 0.02). The OAC group had higher comorbidities, including atrial fibrillation (70% vs 17%), congestive heart failure (28% vs 10%), and hypertension (87% vs 72%), suggesting increased frailty. However, the results were consistent after adjustment for these comorbidities, and was similar regardless of the type of OACs used. Whereas any hemorrhage rates were higher in the OAC group receiving EVT (86% in OAC vs 70% in no OAC), no parenchymal hemorrhage or symptomatic intracranial hemorrhage were observed with OAC use in both the EVT and MM arms. Although we did not find evidence that the effect was due to excess hemorrhage or confounded by underlying cardiac disease or older age, OAC use alone should not exclude patients from receiving EVT. Baseline comorbidities and ischemic injury extent should be considered while making individualized treatment decisions. ANN NEUROL 2024.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Stryker
Informations de copyright
© 2024 American Neurological Association.
Références
January CT, Samuel WL, Hugh C, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol 2019;74:104–132. https://doi.org/10.1016/j.jacc.2019.01.011.
Lyman GH, Carrier M, Ay C, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv 2021;5:927–974. https://doi.org/10.1182/bloodadvances.2020003442.
Goldhoorn RJB, van deGraaf RA, vanRees JM, et al. Endovascular treatment for acute ischemic stroke in patients on oral anticoagulants. Stroke 2020;51:1781–1789. https://doi.org/10.1161/STROKEAHA.119.028675.
Tu HTH, Campbell BCV, Christensen S, et al. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation. Int J stroke Off J Int Stroke Soc 2015;10:534–540. https://doi.org/10.1111/ijs.12007.
Yoshimura S, Sakai N, Yamagami H, et al. Endovascular therapy for acute stroke with a large ischemic region. N Engl J Med 2022;386:1303–1313. https://doi.org/10.1056/NEJMoa2118191.
Sarraj A, Hassan AE, Abraham MG, et al. Trial of endovascular thrombectomy for large ischemic strokes. N Engl J Med 2023;10:1259–1271. https://doi.org/10.1056/NEJMoa2214403.
Huo X, Ma G, Tong X, et al. Trial of endovascular therapy for acute ischemic stroke with large infarct. N Engl J Med 2023;10:1272–1283. https://doi.org/10.1056/NEJMoa2213379.
Bendszus M, Fiehler J, Subtil F, et al. Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open‐label, randomised trial. Lancet 2023;402:1753–1763. https://doi.org/10.1016/S0140-6736(23)02032-9.
Sarraj A, Hassan AE, Abraham M, et al. A randomized controlled trial to optimize patient's selection for endovascular treatment in acute ischemic stroke (SELECT2): study protocol. Int J stroke Off J Int Stroke Soc. 2022;17:689–693. https://doi.org/10.1177/17474930211035032.
Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke‐monitoring study (SITS‐MOST): an observational study. Lancet 2007;369:275–282. https://doi.org/10.1016/S0140-6736(07)60149-4.
Thas O, De Neve J, Clement L, Ottoy J‐P. Probabilistic index models. J R Stat Soc Ser B 2012;74:623–671. https://doi.org/10.1111/j.1467-9868.2011.01020.x.
De Schryver M, De Neve J. A tutorial on probabilistic index models: regression models for the effect size P(Y1<Y2). Psychol Methods 2019;24:403–418. https://doi.org/10.1037/met0000194.
Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:702–706. https://doi.org/10.1093/aje/kwh090.
StataCorp. Stata statistical software: Release 17. Published online 2021.
R Core Team. R: a language and environment for statistical computing, 2021. https://www.r-project.org/.
Rebello LC, Haussen DC, Belagaje S, et al. Endovascular treatment for acute ischemic stroke in the setting of anticoagulation. Stroke 2015;46:3536–3539. https://doi.org/10.1161/STROKEAHA.115.011285.
Chen JH, Hong CT, Chung CC, et al. Safety and efficacy of endovascular thrombectomy in acute ischemic stroke treated with anticoagulants: a systematic review and meta‐analysis. Thromb J 2022;20:35. https://doi.org/10.1186/s12959-022-00394-y.
Meinel TR, Kniepert JU, Seiffge DJ, et al. Endovascular stroke treatment and risk of intracranial hemorrhage in anticoagulated patients. Stroke 2020;51:892–898. https://doi.org/10.1161/STROKEAHA.119.026606.